BINIT SHAH: Open Payments
NPI 1912181389 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$172,813 in 161 payments from 6 companies in 2025. Trend: 2023 $179,504 · 2024 $159,530 · 2025 $172,813
Speaker / faculty: $138,980Travel & lodging: $24,971Consulting: $7,600Food & beverage: $1,262
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 118 | $123,098 |
| Otsuka America Pharmaceutical, Inc. | 36 | $49,571 |
| E.R. Squibb & Sons, L.L.C. | 2 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Janssen Pharmaceuticals, Inc | 2 | $37 |
| Medtronic, Inc. | 1 | $19 |
Products named: INGREZZA, REXULTI, ABILIFY MAINTENA, ABILIFY ASIMTUFII, COBENFY, CAPLYTA, INVEGA SUSTENNA, INCEPTIV.
Industry payments across OH — which companies pay providers there.
